Primary |
Drug Use For Unknown Indication |
70.0% |
Asthma |
20.0% |
Chronic Obstructive Pulmonary Disease |
10.0% |
|
Vomiting |
50.0% |
Urticaria |
25.0% |
Victim Of Abuse |
25.0% |
|
Secondary |
Asthma |
27.1% |
Product Used For Unknown Indication |
20.9% |
Bronchitis |
9.2% |
Chronic Obstructive Pulmonary Disease |
6.8% |
Drug Use For Unknown Indication |
6.5% |
Hypertension |
6.0% |
Insomnia |
2.7% |
Cardiac Asthma |
2.4% |
Epilepsy |
2.4% |
Rheumatoid Arthritis |
2.4% |
Cough |
2.2% |
Bronchial Disorder |
1.6% |
Cardiac Failure |
1.6% |
Hypercholesterolaemia |
1.4% |
Pneumonia |
1.4% |
Borderline Personality Disorder |
1.1% |
Gastritis |
1.1% |
Hyperlipidaemia |
1.1% |
Ill-defined Disorder |
1.1% |
Reflux Oesophagitis |
1.1% |
|
Rhabdomyolysis |
11.1% |
Chest Discomfort |
7.4% |
Pyrexia |
7.4% |
Intestinal Obstruction |
5.6% |
Nausea |
5.6% |
Polydactyly |
5.6% |
Stomatitis |
5.6% |
Vomiting |
5.6% |
White Blood Cell Count Increased |
5.6% |
Angle Closure Glaucoma |
3.7% |
Blood Urea Increased |
3.7% |
Delirium |
3.7% |
Disorientation |
3.7% |
Drug Eruption |
3.7% |
Haematuria |
3.7% |
Hepatic Function Abnormal |
3.7% |
Jaundice |
3.7% |
Liver Disorder |
3.7% |
Muscular Weakness |
3.7% |
Musculoskeletal Stiffness |
3.7% |
|
Concomitant |
Asthma |
24.9% |
Product Used For Unknown Indication |
18.6% |
Drug Use For Unknown Indication |
15.4% |
Hypertension |
6.7% |
Chronic Obstructive Pulmonary Disease |
4.7% |
Rheumatoid Arthritis |
3.2% |
Emphysema |
3.1% |
Insomnia |
2.8% |
Osteoporosis |
2.3% |
Prophylaxis |
2.3% |
Gastritis |
2.1% |
Hypersensitivity |
2.0% |
Depression |
1.9% |
Constipation |
1.9% |
Diabetes Mellitus |
1.6% |
Bronchitis Chronic |
1.5% |
Bronchitis |
1.4% |
Pneumonia |
1.2% |
Pain |
1.2% |
Pruritus |
0.9% |
|
Asthma |
14.4% |
Vomiting |
13.0% |
Pneumonia |
9.6% |
Pyrexia |
6.4% |
Death |
6.1% |
Weight Increased |
5.6% |
Respiratory Failure |
4.8% |
Wheezing |
4.3% |
White Blood Cell Count Decreased |
3.5% |
Hypoglycaemia |
3.2% |
Interstitial Lung Disease |
3.2% |
Rash |
3.2% |
Allergic Granulomatous Angiitis |
2.9% |
Drug Eruption |
2.9% |
Nausea |
2.9% |
Oedema Peripheral |
2.9% |
Tremor |
2.9% |
Vision Blurred |
2.9% |
Gastrointestinal Haemorrhage |
2.7% |
Malaise |
2.7% |
|
Interacting |
Asthma |
33.3% |
Depression |
33.3% |
Hypertension |
33.3% |
|
Henoch-schonlein Purpura |
100.0% |
|